Anti-Human MS4A1 Therapeutic Antibody (D1302A)
D1302A is a novel Type III anti-CD20 antibody that has the functional properties of both Type I (potent CDC activity) and Type II (strong pro-apoptotic activity) antibodies, together with ADCC activity. Conjugation of D1302A with maytansinoids further increases anticancer activity in vitro and in vivo, combining the potent antibody-produced activities with a fourth cytotoxic mechanism distinct from that of other CD20 targeted agents.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-1694CL |
| Pricing | Inquiry |
| Type | Humanized antibody |
| Host | Human |
| Target | CD20 |